Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy

Author： Coluccia AML   Gunby RH   Tartari CJ   Scapozza L   Gambacorti-Passerini C   Passoni Lorena  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.3, 2005-06, pp. : 515-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase as a therapeutic target

By Kruczynski Anna   Delsol Georges   Laurent Camille   Brousset Pierre   Lamant Laurence  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of anaplastic lymphoma kinase: a patent review

By Milkiewicz Karen L   Ott Gregory R  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1653-1681

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review

By Mesaros Eugen F   Ott Gregory R   Dorsey Bruce D  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 417-442

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic Lymphoma Kinase Expression and Prognosis in Inflammatory Myofibroblastic Tumours of the Maxillary Sinus

By Lu Z-J   Zhou S-H   Yan S-X   Yao H-T  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 2000-2008

Field House Publishing

Access to resources Recommend Favorite